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Abstract
Background: In the present pilot study we applied recently published protocols for detecting
Mycobacterium tuberculosis in human remains. We screened long bones from an 18th century
cemetery and skulls from the anatomical "Weisbach collection" (19th century). In addition, besides
the study of abundance of tuberculosis in inmates of the poorhouse itself, we were interested to
test whether in this particular instance tuberculosis can be identified from cortical bones, which
are rarely affected by tuberculosis, but mostly better preserved than the vertebral bodies or
epiphyses.
Method: The DNA extractions from the bone samples were obtained following established
ancient DNA protocols. Subsequently extracts were subjected to a series of PCR amplifications
using primer pairs published previously [1,2]. PCR products of the expected size were subsequently
sequenced.
Results: Only primers targeting the repetitive IS6110 insertion sequence yielded PCR products of
appropriate size. In one sample only (skull sample WB354 of the "Weisbach collection") sequence
analysis revealed an authentic M. tuberculosis sequence that matched to a reference sequence from
GenBank.
Conclusion: With a variety of established PCR approaches we failed to detect M. tuberculosis
DNA in historic human femurs from an 18th century cemetery relating to a poor house in
Kaiserebersdorf, Austria. Our data may indicate that in this particular case, thoracic or lumbar
vertebrae, i.e. bones that are severely affected by the disease, would be more suitable for molecular
diagnostics than long bones. However, the unpredictable state of DNA preservation in bones from
museum collections does not allow any general recommendation of any type of bone.
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Bone tuberculosis (Spondylitis tuberculosa, "Pott's disease")
and joint tuberculosis are caused by Mycobacterium tuber-
culosis and appear among others as late manifestations of
a tuberculosis infection. Because of the inflammatory
bony changes, e.g., partial or total destruction of the ver-
tebral bodies or joint elements, manifestations of tubercu-
losis infections of (pre)historic human skeletal remains
are very often identifiable by means of macroscopic
inspections. Since the spread of M. tuberculosis depends on
population density, its verification is also of high interest
for the reconstruction of population dynamic processes in
archaeology and anthropology [3]. Nevertheless, post
mortem destructions with substantial substance loss or
other pathologies with a similar appearance such as, e.g.,
destruction and remodeling of joint surfaces caused by a
fracture and dislocation of a joint element, or an idio-
pathic avascular necrosis of the femoral head, may lead
occasionally to erroneous diagnoses, which may miss- or
under-represent the prevalence of tuberculosis in past
human populations. An unambiguous molecular identifi-
cation of tuberculosis for historic human bone remains
has therefore been highly appreciated by anthropologists
and paleo-epidemiologists.
In recent years, tuberculosis has been diagnosed from a
variety of historic human bone remains using ancient
DNA methodology. Spigelman and Lemma [4] were the
first to detect authentic DNA of M. tuberculosis in pre-Euro-
pean-contact human remains from Borneo by means of
PCR amplification. This study has been criticized to some
extent for technical issues, but the results were confirmed
some ten years later [5]. Other examples of detecting M.
tuberculosis in historic samples include ancient Egyptian
mummies [6] and twelve approximately 140 – 1,200 years
old mummies excavated from the Andes Mountain region
of South America [1]. In seven samples Mycobacterium
DNA could be detected out of which two proved positive
for M. tuberculosis. In another study several loci of the M.
tuberculosis genome were targeted in DNA extracted from
naturally mummified remains from three 18th century
individuals from Hungary by means of PCR and spoligo-
typing [7], and M. tuberculosis rather than Mycobacterium
bovis was identified as the cause of the disease. Taylor et al.
[2] were able to confirm the morphology based diagnosis
of tuberculosis for approximately 2,200 years old human
remains excavated from Tarrant Hinton, Dorset, United
Kingdom, using a series of sensitive PCR amplifications.
In addition, they identified a member of the "modern"
type of M. tuberculosis and excluded other strains such as
M. bovis as the source of infection of this particular indi-
vidual. More recently, M. tuberculosis DNA could also be
genotyped from five Iron Age individuals from Aymyrlyg,
South Siberia [8]. So far, the most comprehensive studies
have been conducted by Zink et al. [9,10]. Remains of 41
individuals from the ancient Egyptian population (3,000-
500 BC) have been screened for M. tuberculosis, among
them 21 samples without morphological osseous
changes. M. tuberculosis was detected in 9 samples includ-
ing 2 cases without pathological bone changes [9]. In
2005, Zink et al. [10] screened numerous samples of dif-
ferent age and origin, and determined high frequencies of
tuberculosis infections in historic populations.
Most studies mentioned above used either dried skin [1]
or thoracic and lumbar vertebrae as well as ribs [2,8], i.e.
those parts of the skeleton that are affected most by Pott's
disease, as sources for DNA extractions. Nevertheless, to
some extent long bones have been shown suitable for
detection of M. tuberculosis, e.g., Fusegawa et al. [11],
although vertebrae, spines, and ribs remain the preferred
samples. Zink et al. [10] also screened 51 long bones for
the presence of M. tuberculosis, and showed that such sam-
ples may also be suitable for investigating osseous tuber-
culosis, although with probably lower success rate.
In the present pilot study, we screened 10 long bones from
the 18th century burials of the Kaiserebersdorf castle, Aus-
tria, for M. tuberculosis DNA. In addition to study the
abundance of tuberculosis in inmates of the poorhouse
itself, we were interested to test whether in this particular
instance tuberculosis can be identified from cortical bones
(here we used the most robust element, the femur). Such
bones are rarely affected by tuberculosis but are frequently
much better preserved than the vertebral bodies or epi-
physes, and preservation of authentic ancient DNA in the
bones' middle regions has been shown likely [12].
According to historical sources, the cemetery was localized
close to a chapel and a poor house, which was established
by the Habsburg empress Maria Theresia. The skeletal
remains of 34 individuals were systematically investi-
gated, and 24 individuals were identified as elder females.
Nearly all individuals exhibited severe skeletal changes or
pathological alterations. Among them not only progres-
sive degenerative joint lesions indicating long-lasting hard
labor, but also features such as cribra orbitalia (anemia),
chronic Vitamin C deficiency (newly build bone struc-
tures and porosities) and Vitamin D deficiency (rachitic,
osteomalacia, osteoporosis) as well as severe inflamma-
tions (meningitis and sinusitis) and symptoms of infec-
tious diseases such as syphilis and tuberculosis were
observed [13].
Methods
Samples
All samples were taken from the collections housed at the
Department of Anthropology, Natural History Museum
Vienna, Austria. Ten samples were taken from the mid-
shaft femur of ten different individuals recovered from the
burial site at the castle of Kaiserebersdorf, south-east ofPage 2 of 6
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KE23, KE26c, KE29. [5]. Tuberculosis was clearly identi-
fied in one individual (KE20), a well preserved skeleton of
an end-mature female, which shows characteristic osteo-
lytic changes among two vertebral bodies and the adjacent
portion of the os sacrum. Individual KE23, a mature
female, very likely represents a case of beginning joint
tuberculosis. The proximal metaphysis of the left ulna
shows an active osteolytic process in form of a cavity.
From an anthropological point of view, the inmates of the
poor house in Kaiserebersdorf represent a group of hard
working, extremely insufficiently nourished people. It is
considered likely that infectious diseases such as tubercu-
losis have spread within this community.
As positive controls, three bone samples (core samples
obtained from skull vaults) from the anatomical
"Weisbach collection", dated to the end of the 19th cen-
tury were used. Individual data such as sex, age-of-death,
and cause-of-death were recorded in handwritten proto-
cols [14]: WB 565, a 22 year old male, died from menin-
gitis tuberculosa. The internal layer exhibits no signs of
inflammation, but many small (1–2 mm in diameter),
often confluent depressions, which have been interpreted
as features of tubercles. WB 354, a 24 year old male, died
from tuberculosis of the peritoneum. The internal layer
shows few very tiny new bone formations within the sag-
ittal sinus and small depressions by tubercles in the mid-
dle and occipital cranial base. The sample has been taken
from a pathomorphologically completely inconspicuous
region of the skull. WB 594, a 22 year old male, died from
tuberculosis of the peritoneum and meningitis. The inter-
nal lamina shows slight newly build bone structures
within the sinus and imprints of tubercles exclusively at
the posterior cranial base. These skull remains are macro-
scopically well preserved because they have never been
exposed to soil.
Finally, two bone samples (also from the midshaft femur)
were taken from the site Hainburg (Lower Austria) that
dates back to the early Bronze Age (ca. 2,000-1,500 BC):
HB284 (a female, age-of-death 21–24), and HB310 (a
female, age-of-death 30–35). From this epoch, bones with
morphological alterations due to tuberculosis have never
been reported from Austrian localities (Ninvestigated =
2000). Therefore, we considered them as negative con-
trols.
DNA extraction, PCR, and DNA sequencing
Small samples were chopped off the bones and ground
into a fine powder using a mortar under liquid nitrogen.
Approximately 0.1–0.3 gram of bone powder was subse-
quently transfered into a 2.0 ml screw-capped centrifuge
tube and DNA was extracted according to the silica based
protocol with modifications [15,16].
The DNA extracts were subjected to a series of PCR ampli-
fications using primer pairs (table 1) previously described
[1,2]. The primer pairs proposed by [1] target the insertion
sequence IS6110. This insertion was shown to be specific
Table 1: Primers used for amplifying M. tuberculosis target DNA
Primer Length of product Sequence 5' – 3' Reference
IS1081_F2 135 bp CTGCTCTCGACGTTCATCGCCG Insertion sequence IS1081
IS1081_R2 GGCACGGGTGTCGAAATCACG [2]
IS1081_R3 113 bp TGGCGGTAGCCGTTGCGC
OxyR_F3 110 bp CACTGCCTACGCGACCAGACG oxidative stress regulator OxyR pseudogene
OxyR _R1 TCTGCGGAATCAGTGTCACC [2]
OxyR _F4 94 bp AGACGCTCGATGCTGCCCAA
pncA_F2 117 bp GGCGGACTACCATCACGTCG Pyrazinamidase gene
pncA _R2 GGAGTACCGCTGACGCAATGCGGT [2]
pncA _R3 96 bp GGCCACGACGAGGAATAGTC
D1flanking_F 112 bp ATCGAAAGGCTAACGGGTGC flanking sections of TbD1 region
D1flanking _R2 CTGCTCGCCGAGTTGGTCGATA [2]
D1flanking _R3 96 bp TCGATACCGTCGATCGTGTCAAAG
D1internal _F3 115 bp CGAGCTACGACGCTCGCTATTA TbD1 region
D1internal _R3 GCATATCGTGATCCGTCTCGAT [2]
D1internal _R4 105 bp CTCGATCATCAGTAGTTCGGGATTC
TbA TbA/TbB: CTCGTCCAGCGCCGCTTCGG insertion sequence IS6110
TbB 120 bp CCTGCGAGCGTAGGCGTCGG [1]
TbC TbC/TbD: GCTTCGGACCACCAGCACCT
TbD 95 bp GCGTCGGTGACAAAGGCCAC
For the primers of [2], F (forward) and R (reverse) denote orientation of the primer and for each gene amplification was performed with the first 
two primers followed by reamplification with the third primer in combination with one of the original primers.
Target Sequences: IS108 = Insertion sequence IS1081; OxyR = oxidative stress regulator OxyR pseudogene; pncA = Pyrazinamidase gene; D1 = 
TbD1 region described in [25] that is deleted in modern strains of M. tuberculosis; TbA-TbD: insertion sequence IS6110.Page 3 of 6
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copy number in most M. tuberculosis strains [18]. Target-
ing the IS6110 insertion sequences in the M. tuberculosis
genome is considered the most sensitive approach [19],
and, therefore, most frequently applied. The primer pairs
taken from [2] target five different regions of the M. tuber-
culosis genome, including the repetitive IS1081 insertion
sequences.
PCR amplifications were performed using the PfuTurbo
DNA polymerase (Stratagene, La Jolla, CA, USA) or the
DyNAzyme (Finnzymes, Espoo, Finland) DNA polymer-
ase in 1× Reaction Buffer, 0.2 mmol/L of each dNTP,
0.04% bovine serum albumin (BSA), 1 μmol/L of each
primer, and 2 μL of DNA extract (DNA concentration not
quantified). Thermal cycling conditions were: 94°C for 2
min; 32 cycles of 94°C for 50 sec, 48° – 60°C for 50 sec,
and 72°C for 1 min; and a final extension at 72°C for 10
min. PCR products were purified for direct sequencing
using 8 μL 10× diluted exoSAP-IT solution (USB Corpora-
tion, Cleveland, OH, USA) per reaction. Cycle sequenc-
ing, using the same primers as in the PCR reaction, was
performed in 10 μL reactions using 2 μL BigDye Termina-
tor Cycle Sequencing Ready Reaction Kit (Applied Biosys-
tems, Foster City, CA, USA), 2 μL 5× Sequencing Buffer, 10
pmol primer, and 3 μL purified PCR product. Sequencing
products were purified with ethanol precipitation and
analyzed using an ABI 3100 Genetic Analyzer (Applied
Biosystems, Foster City, CA, USA).
PCR products that could not be sequenced directly were
cloned in the pCR4Blunt-TOPO plasmid vector by means
of the TOPO TA Cloning Kit (Invitrogen) and individual
clones were subsequently sequenced.
Inhibitory effect of DNA extracts
Ancient DNA extracts may contain PCR inhibiting compo-
nents that can cause misleading results. In such instances
failure to obtain PCR products cannot be assigned to the
absence of the target DNA but simply to inhibition of the
reaction. In order to test for co-extracted PCR inhibitors in
the samples used in the current study, established test
PCRs targeting a ~1000 bp and a ~300 bp fragment of the
mitochondrial genome of microtine rodents were spiked
with ancient DNA extracts. Spiking PCR amplifications
[20] were performed in a final volume of 25 μL using the
Taq DNA polymerase (Roche) in 1× Reaction Buffer, 0.2
mmol/L of each dNTP, 1 μmol/L of each primer, 50 ng
genomic DNA of Microtus maximowiczii and 2 μL of DNA
extract (DNA concentration not quantified). Thermal
cycling conditions were: 94°C for 2 min; 35 cycles of
94°C for 20 sec, 56°/57°C for 30 sec, and 72°C for 60/40
sec; and a final extension at 72°C for 7 min. The primers
were Pro+ (5'-ACC ATC AGC ACC CAA AGC TG-3') and
Phe- (5'-AAG CAT TTT CAG TGC TTT GCT T-3') for the
~1000 bp fragment, and Pro+ and mico3- (5'-GTA AAA
GAA GCA TTA ATT AAA-3') for the ~300 bp fragment [21].
None of the ancient DNA extracts inhibited amplification
of the test PCRs, as assessed by three replicates. PCR inhi-
bition through ancient DNA extracts was therefore not
considered a significant problem for the selected samples.
Precautions against contamination
The bone samples were processed independently in the
DNA labs of the Natural History Museum Vienna and the
Natural History Museum Oslo following standards to
avoid contamination of samples: These include in partic-
ular, usage of DNA, DNAse, and RNAse-free consumables
and reagents, as well as pipette tips with aerosol protec-
tion filters, and UV-treatment of tubes prior to extraction
and PCR amplifications. Negative controls for extractions
(without any sample) as well as PCR reactions (without
any DNA) were included in the experimental setup. The
samples from Hainburg (Lower Austria, Bronze Age) were
considered as additional negative controls. Samples from
presumably TB-containing cases were never processed
before the experiments on the negative controls and sam-
ples of unknown infection status had been finished. In
both labs no studies of modern mycobacterial or human
DNA had been performed before, and especially no mod-
ern mycobacterial DNA was used as positive PCR controls.
Results
When subjecting the long bone samples from Kaisereber-
sdorf, Austria, as well as the positive and negative controls
to PCR amplification targeting various regions in the
genome of Mycobacterium tuberculosis, several PCR prod-
ucts were obtained. OxyR amplified for the skull WB594
using the primer pair R1/F4. The PCR targeting the IS6110
insertion sequences yielded PCR products of appropriate
size for the skulls WB354, WB565, and WB594 using
primer pair TbA/TbB, and for the long bones KE23 and
HB284, and the skulls WB354 and WB594 using primer
pair TbC/TbD.
When sequencing the obtained PCR products only
WB354 amplified with the primer pair TbC/TbD yielded a
sequence identical with the targeted IS6110 insertion
sequences of M. tuberculosis (reference sequence: AF
181860), and was therefore considered positive. The
sequence has been deposited in GenBank under the acces-
sion number FJ177511. None of the other cloned PCR
products yielded sequences with similarity to M. tubercu-
losis but proved unspecific PCR amplification (sequence
similarity to, e.g., sequences from Pseudomonas or various
fungi).
With the exception of the unspecific amplification of non-
target DNA of samples KE23 and HB284 when using the
TbC/TbD primer pair, DNA extracts from long bonesPage 4 of 6
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band of appropriate size on ethidium-bromide stained
agarose gels. Even reamplification attempts were negative
for the various primer pairs.
Discussion
In the present study we aimed at diagnosing tuberculosis
in historic human long bones from 18th century burials in
Kaiserebersdorf, Austria. A positive result, i.e., PCR ampli-
fication of a DNA fragment with a nucleotide sequence
matching the IS6110 insertion sequences of M. tuberculosis
deposited in GenBank, was only obtained for the skull
WB354. This was not unexpected since this sample served
as positive control and tuberculosis had been diagnosed
earlier in this individual by means of the spoligotyping
approach [14]. The amplification of the IS6110 insertion
sequence proofs the suitability of the applied PCR
approach. However, also for this sample positive PCR
amplification was only obtained with the primer pair
TbC/TbD that targets the repetitive insertion sequences
IS6110, but not for any of the other molecular markers
tested. This may indicate that only very limited amount of
template DNA could be extracted from this particular
sample. The failure to amplify any tuberculosis specific
target DNA from the other positive skull samples may fur-
ther support this interpretation. It should be considered
that a M. tuberculosis strain which did not contain IS6110
has been reported earlier [22]. Thus, the use of IS6110 as
a single marker for PCR-facilitated detection M. tuberculo-
sis might be insufficient. Nevertheless, the IS6110 inser-
tion sequence is very likely the most sensitive marker [19]
in the M. tuberculosis genome and yielded positive results
while other markers such as, e.g., oxyR failed [23].
However, even the IS6110 insertion sequence could not
de determined in the long bones of the samples KE20 and
KE23 from the poor house in Kaiserebersdorf, Austria.
Given the difficulties in amplifying target DNA of M.
tuberculosis in the positive skull samples, it may not be sur-
prising that none of the test bones from the burials in Kai-
serebersdorf yielded any specific PCR product, although it
seems likely from other anthropological evidence that at
least samples KE20 and KE23 relate to individuals that
suffered from tuberculosis.
Several reasons can account for the negative results on the
long bone samples from Kaiserebersdorf: First, some indi-
viduals may not have suffered from tuberculosis. This can
almost certainly be excluded for samples KE20 and KE23.
Second, no DNA was preserved in the samples from Kai-
serebersdorf. With the data at hand, we can currently not
reject such interpretation. We refrained from amplifying
other human target DNA in order to test for the presence
of amplifiable DNA. The human actin gene has been sug-
gested for this purpose [24]. However, the samples from
Kaiserebersdorf have been handled extensively by
humans, and proof of authenticity of any human target
DNA would have been close to impossible. Third, the
presence of PCR inhibitors in the DNA extracts may have
prevented successful amplifications. According to the
results of our spiking experiments, this option can be
excluded. No sample from Kaiserebersdorf, Austria, pre-
vented successful amplification of high quality test DNA.
A further reason for the failure of amplifying M. tuberculo-
sis DNA from the samples from Kaiserebersdorf may relate
to the bone samples themselves. Long bones such as, e.g.,
the femurs that are rarely affected by tuberculosis may rep-
resent material that is hardly suitable for the molecular
detection of M. tuberculosis. This interpretation may hold
for the particular samples under study, but it has been
shown earlier that M. tuberculosis can be detected in his-
toric femur samples [10] although with probably lower
success rate.
Conclusion
In the current study, we failed to positively diagnose
tuberculosis in DNA extracts from historic human long
bones from inmates of a poor house in Kaiserebersdorf,
Austria. Using thoracic or lumbar vertebrae for diagnosing
tuberculosis, i.e., bones that are severely affected by the
disease might have been more successful than long bones.
This issue will be further explored in a future study. We
conclude that the unpredictable state of DNA preservation
in bones from museum collections does not allow any
general recommendation of any type of bone.
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